CMC development of (R)-VK4-116 dihydrochloride salt
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,795,195
Award facts
- Opportunity
-
- 75N95020R00043 Solicitation number
- Contract value 100% obligated
- $1,795,194.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,073 | |
| Funding Only Action | -$294 | |
| Supplemental Agreement for work within scope | $127,314 | |
| Exercise an Option | $106,395 | |
| Exercise an Option | $431,401 | |
| Supplemental Agreement for work within scope | $380,538 | |
| Original award | $758,914 |
About this award
The National Institute on Drug Abuse issued a delivery order to Curia Global Inc. on September 21, 2020, with a ceiling value of $1,795,194.50, for development of (R)-VK4-116 dihydrochloride salt and contract research organization support for NCATS drug substance development and manufacture.
This delivery order was issued under the CRO Support for NCATS Drug Substance Development and Manufacture parent IDIQ to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 closing of fund availability. Place of performance is Albany, NY. Ultimate completion date is March 31, 2026.
The order carries cost-plus-fixed-fee pricing. Service Contract Inventory reporting shows a rising labor footprint: FY2024 (most recent) invoiced $1.7 million across 6.7 FTEs and 14,014 contractor hours at a derived government-paid rate of $124.53 per hour. Curia Global performed all reported hours without subcontractor engagement. Government-paid hourly rates rose from $103.60 in FY2021 to $124.53 in FY2024.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 21, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $1,795,195 on 75N95020F00002.
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under HHSN271201700005I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award